LAI patient status/conversations, n (%) | Patients on oral antipsychotics | Patients on LAIs |
---|---|---|
 | (n = 22) | (n = 38) |
 Previously treated with LAIa | 3 (14) | NA |
  Discussion of oral treatment | 3 | NA |
  Discussion of LAI treatment | 3 | NA |
 Oral with discussion of LAI | 8 (36) | NA |
  Discussion of oral treatment | 8 | NA |
  Discussion of LAI treatment | 8 | NA |
 No discussion of LAI | 11 (50) | NA |
  Discussion of oral treatment | 11 | NA |
  Discussion of LAI treatment | 0 | NA |
 LAI discontinuation | NA | 1 (3) |
  Discussion of oral treatment | NA | 1 |
  Discussion of LAI treatment | NA | 1 |
 LAI restart | NA | 2 (5) |
  Discussion of oral treatment | NA | 2 |
  Discussion of LAI treatment | NA | 2 |
 LAI-to-LAI switch | NA | 3 (8) |
  Discussion of oral treatment | NA | 3 |
  Discussion of LAI treatment | NA | 3 |
 New start on LAI | NA | 11 (29) |
  Discussion of oral treatment | NA | 9 |
  Discussion of LAI treatment | NA | 11 |
 LAI continuation | NA | 21 (55) |
  Discussion of oral treatment | NA | 13 |
  Discussion of LAI treatment | NA | 21 |
LAIs used in treatment, n (%) | ||
  First-generation LAIs | NA | 8 (21) |
  Second-generation LAIs | NA | 30 (79) |